www.Top100Medicine.com - TOP 100 MEDICAL SITES
TOP 100 MEDICAL SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Webmaster 
Updated Sat, February 4, 2012.
751.www.atrovent.com78
752.www.annuaire-medecine-esthetique.com68
753.csd23.blogspot.com66
754.www.umc-utrecht.nl57
755.www.depo-medrol.com47
756.www.pictureshop.blogspot.com31
757.www.misa.us14
758.cicil.ukl.uni-freiburg.de9
759.www.docsplanet.com9
760.www.luigigrosso.net9
761.www.telemedicine24-7.com8
762.www.niaclin.com8
763.ameditic.blogspot.com8
764.myrenovate.com7
765.journaldunpharmacien.hostse.com7
766.www.easylapband.com6
767.www.praxis-sievering.com5
768.videosdemedecine.blogspot.com5
769.www.fropus.com4
770.www.healthorlando.com2
771.www.field-home-test.info2
772.www.amgpa.org2
773.www.thenaturalheal.com1
Pages:  1  2  3  4  5  6  7  8  9  10  11  12 
 13  14  15  16 



Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Newsvine

762. www.niaclin.com

Rating: 8 points*
*amount mentions of word 'www.niaclin.com' on the other websites

www.niaclin.com

NIACLIN - Fast advisor for medical symptoms

Description: This page is a medical expert system dedicated to medical diagnosis on line

Google

© 2005-2012 www.Top100Medicine.com
Is SIGA Still Worth the Wait?
VFC submits: Shares of SIGA Technologies have approached the eight dollar level of late, rebounding nicely from the low of under five dollars about six months ago. The SIGA stock reached a high of over ten bucks last December in anticipation of a possible awarding of a BARDA contract for the ST-246 smallpox vaccine. The contract did not pan out at the time, although some modifications to the application process in the interest of creating competition were announced around that time.A $2.8 million contract was awarded to Siga by the Department of Defense in early March, although this one was for ST-669, a broad-spectrum anti-viral. Complete Story »
seekingalpha.com
Enzo Biochem Reports Third Quarter Operating Results (Business Wire)
NEW YORK----Enzo Biochem, Inc. , a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, today reported financial results for the three and nine months ended April 30, 2010.
us.rd.yahoo.com
NPS Pharmaceuticals, Inc. Q2 2010 Earnings Conference Call Transcript
NPS Pharmaceuticals, Inc. Q2 2010 Earnings Conference Call August 4, 2010 17:00 E.TComplete Story »
seekingalpha.com
Roche Bets Big on Peptides for Tackling Tough Diseases
The Burrill Report submits: By Michael FitzhughRoche (RHHBY.PK) is investing $25 million to back a drug-delivery technology developed by Aileron Therapeutics, a small company that stands to earn $1.1 billion in milestone payments plus royalties should its technology help Roche develop successful new medicines. Complete Story »
seekingalpha.com
CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at 'The Marijuana Conference' in New York City on Oct. 25 & 26
[PR Newswire] - Cannabis Science, Inc. , a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce the upcoming coverage by CNBC, Discovery Channel and National Geographic for the speaking engagement of Dr.
us.rd.yahoo.com